このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Pharma Aids マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Faizul Hassan

最高経営責任者

৳35.0k

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	10.8%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

CEO（最高経営責任者

Faizul Hassan (75 yo)

no data

在職期間

৳35,000

報酬

Mr. Faizul Hassan serves as the Chief Executive Officer, Managing Director and Director of Pharma Aids Limited.

Pharma Aids マネジメント

マネジメント基準チェック /24

主要情報

経営陣の近況

Less than half of directors are independent

Less than half of directors are independent

Pharma Aids Limited, Annual General Meeting, Dec 24, 2020

Recent updates

Third quarter 2024 earnings released: EPS: ৳7.46 (vs ৳1.21 loss in 3Q 2023)

Pharma Aids Limited to Report Q3, 2024 Results on Apr 24, 2024

Second quarter 2024 earnings released: EPS: ৳7.21 (vs ৳0.76 loss in 2Q 2023)

Pharma Aids Limited to Report Q2, 2024 Results on Jan 30, 2024

Full year 2023 earnings released: ৳2.05 loss per share (vs ৳11.14 profit in FY 2022)

Pharma Aids Limited Recommends Cash Dividend for the Year Ended June 30, 2023

Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023

Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023

Third quarter 2023 earnings released: ৳1.21 loss per share (vs ৳4.63 profit in 3Q 2022)

Second quarter 2023 earnings released: ৳0.76 loss per share (vs ৳5.53 profit in 2Q 2022)

Upcoming dividend of ৳5.00 per share

Less than half of directors are independent

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of ৳5.00 per share

New 90-day low: ৳393

New 90-day high: ৳472

Pharma Aids Limited, Annual General Meeting, Dec 24, 2020

Pharma Aids Limited to Report Q1, 2021 Results on Nov 12, 2020

New 90-day high - ৳506

Pharma Aids Limited to Report Q3, 2020 Results on Jun 24, 2020

CEO（最高経営責任者

在職期間

報酬

Pharma Aids マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Less than half of directors are independent

Less than half of directors are independent

Pharma Aids Limited, Annual General Meeting, Dec 24, 2020

Recent updates

Third quarter 2024 earnings released: EPS: ৳7.46 (vs ৳1.21 loss in 3Q 2023)

Pharma Aids Limited to Report Q3, 2024 Results on Apr 24, 2024

Second quarter 2024 earnings released: EPS: ৳7.21 (vs ৳0.76 loss in 2Q 2023)

Pharma Aids Limited to Report Q2, 2024 Results on Jan 30, 2024

Full year 2023 earnings released: ৳2.05 loss per share (vs ৳11.14 profit in FY 2022)

Pharma Aids Limited Recommends Cash Dividend for the Year Ended June 30, 2023

Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023

Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023

Third quarter 2023 earnings released: ৳1.21 loss per share (vs ৳4.63 profit in 3Q 2022)

Second quarter 2023 earnings released: ৳0.76 loss per share (vs ৳5.53 profit in 2Q 2022)

Upcoming dividend of ৳5.00 per share

Less than half of directors are independent

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of ৳5.00 per share

New 90-day low: ৳393

New 90-day high: ৳472

Pharma Aids Limited, Annual General Meeting, Dec 24, 2020

Pharma Aids Limited to Report Q1, 2021 Results on Nov 12, 2020

New 90-day high - ৳506

Pharma Aids Limited to Report Q3, 2020 Results on Jun 24, 2020

CEO（最高経営責任者

在職期間

報酬

マネジメント基準チェック /24